The purpose of the study is to assess Oxford Hip Score at baseline, at 2 months and at over 12 months.
Age ≥ 18 years old;
Definite diagnosis of iliopsoas tendinopathy due to conflict between the tendon and the prosthetic cup;
Failure of first-line conservative treatment;
Planned endoscopic tenotomy;
Revision total hip prosthesis, multiple operations prior to tenotomy;
Other surgical or medical interventions planned during the study;
Participation in another clinical trial, or during a period of exclusion from another clinical trial;
Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
Parallel
Endoscopic tenotomy surgery of the iliopsoas tendon
Procedure/SurgeryThe surgery will be performed under general anesthesia with standardized multimodal analgesia. Whatever the techniques, the approaches, the instruments to perform the procedure and the postoperative course will be identical, as in usual practice.
Oxford Hip Score
Compare the clinical improvement experienced by patients having an endoscopic tenotomy of the iliopsoas tendon at the level of the lesser trochanter versus at the level of the notch at more than 1 year minimum. The Oxford Hip Score is a self-administered patient-administered 12-item "Patient Reported Outcome Measures" questionnaire that allows the surgeon to assess clinical outcomes after total hip replacement.
Click on the lead sponsor to view all of their trials.
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead sponsor
Euraxi Pharma
Collaborator
